期刊文献+

胶囊内镜对老年不明原因消化道出血的诊断及再出血因素分析 被引量:2

Diagnostic value of capsule endoscopy in elderly patients with obscure GI bleeding and analysis of factors for rebleeding
暂未订购
导出
摘要 目的 评估胶囊内镜对老年不明原因消化道出血的诊断价值,并通过长期随访结果分析其再出血率及其影响因素。方法入选2002年5月至2008年2月间因不明原因消化道出血在本院行胶囊内镜检查的老年患者127例,评估受检患者的耐受性和诊断率,并随访根据诊断结果实施的治疗效果、再出血率及其影响因素。结果127例受检者中阳性诊断率为66.1%,其中以血管病变为最主要诊断,其次为肿瘤和克罗恩病,分别为59.5%、16.7%和11.9%。剔除10例失访者后,经随访发现117例中再出血率为41%,其中阳性诊断组为48-8%(38/78),阴性诊断组为25.7%(10/39),两组具有统计学差异(P〈0.05);而阳性诊断组中非血管病变者再出血率为24.2%(8/33),血管病变者为66.7%(30/45),同样具统计学差异(P〈0.01)。结论胶囊内镜对于老年不明原因消化道出血患者是一项安全有效的检查手段。胶囊内镜诊断中以非血管性病变及阴性者再出血率低,而血管病变者再出血率高。 Objective To evaluate the diagnostic value of capsule endoscopy (CE) in elderly patients with obscure GI bleeding, and analyze factors for rebleeding through long-term follow-ups. Methods Included in the present study were 127 elderly patients with OGIB referred to our hospital for CE between May 2002 and February 2008. Patient tolerance to CE and the diagnostic rate were observed. The outcome, rebleeding and factors affecting rebleeding were analyzed through long-term follow-ups. Results The overall diagnostic Tate of CE was 66.1% in 127 patients with OGIB. The most common findings were vascular lesions, including angiodysplasia (59.5%), neoplasia (16.7%) and Crohn's disease (11.9%). Bleeding recurrence was found in 41% of 117 patients during the follow-up, and the remaining 10 patients we.re lost to the follow-up. The rebleeding rate was significantly higher in patients with positive CE than in those with negative CE (48.8% vs 25.7%, P〈0.05). In patients with positive CE findings, the rebleeding rate in non angiodysplasic patients was 24.2% (8/33) versus 66.7 % (30/45) in angiodysplasic patients (P 〈 0.01). Conclusion Capsule endoscopy is a safe and effective procedure for elderly patients with OGIB. The rebleeding rate was lower in non angiodysplasic and CE negative patients than that in angiodysplasic patients.
出处 《老年医学与保健》 CAS 2008年第6期355-357,376,共4页 Geriatrics & Health Care
基金 上海市重点学科建设资助项目(编号:Y0205)
关键词 胶囊 内窥镜检查 胃肠出血 老年人 Capsules Endoscopy Gastrointestinal Hemorrhage Aged
  • 相关文献

参考文献18

  • 1Mishkin DS, Chuttani ER, Croffie J, et al. ASGE Technology Status Evaluation Report: wireless capsule endoscopy. Gastroinest Endosc, 2006,63 (4): 539-545.
  • 2Triester SL, Leighton JA, Leontiadis GI et. al A meta-analysis of the yield of capsule endoscopy compared to other diagnostic modalities in patients with Obscure Gastrointestinal Bleeding. Am J Gastroenterol, 2005,100 (11): 2407-2418.
  • 3Fireman Z, Friedman S. Diagnostic yield of capsule endoscopy in obscure gastrointestinal bleeding: Digestion, 2004,70 (3): 201-206.
  • 4Albert JG, et al. Performance of capsule endoscopy in obscure intestinal bleeding. A multicenter outcome study. DDW, 2006,130 (4): AB T1108.
  • 5Pennazio M, Eisen G, Goldfarb N. ICCE consensus for obscure gastrointestinal bleeding. Endoscopy, 2005,37: 1046-1050.
  • 6Askin MP, Lewis BS. Push enteroscopic cauterization: long- term follow-up of 83 patients with bleeding small intestinal. Gastromtest Endosc, 1996,43 (6): 580-583.
  • 7Morris A J, Mokhashi M, Straiton M, et al. Push enteroscopy and heater probe therapy for small bowel bleeding. Gastromtest Endosc, 1996,44 (4): 394-397.
  • 8Kovacs TO, Jensen DM. Recent advances in the endoscopic diagnosis and therapy of upper gastrointestinal, small intestinal and colonic bleeding. Med Clin North Am, 2002,86 (6) 1319-1356.
  • 9Ibrarullah M, Wagholikar G D. Dieulafoy's lesion of duodenum: a case report. BMC Gastroenterol, 2003,3: 2.
  • 10Matsushita M, Hajiro K, Takakuwa H, et al. Laparoscopically assisted panenteroscopy for gastrointestinal bleeding of obscure origin. Gastrointest Endosc, 1997,46: 474-475.

二级参考文献10

  • 1Selby W. Can clinical features predict the likelihood of finding abnormalities when using capsule endoscopy in patients with GI bleeding of obscure origin? Gastrointest Endosc, 2004, 59: 782-787.
  • 2Gerson LB, Van Dam J. Wireless capsule endoscopy and double-balloon enteroscopy for the diagnosis of obscure gastrointestinal bleeding. Tech Vase Interv Radiol, 2004,7: 130-135.
  • 3Junquera F, Feu F, Papo M, Videla S, Armengol JR,Bordas JM, Saperas E, Pique JM, Malagelada JR. A multicenter, randomized, clinical trial of hormonal therapy in the prevention of rebleeding from gastrointestinal angiodysplasia. Gastroenterology, 2001, 121: 1073- 1079.
  • 4Nordquist LT, Wallach PM. Octreotide for gastrointestinal bleeding of obscure origin in an anticoagulated patient.Dig Dis Sci, 2002, 47: 1514-1515.
  • 5D'Amato RJ, Loughnan MS, Flynn E, Folkman J.Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci U S A, 1994, 91: 4082-4085.
  • 6Junquera F, Saperas E, de Torres I, Vidal MT, Malagelada JR. Increased expression of angiogenic factors in human colonic angiodysplasia. Am J Gastroenterol, 1999, 94:1070-1076.
  • 7Ozawa CR, Banfi A, Glazer NL, Thurston G, Springer ML,Kraft PE, McDonald DM, Blau HM. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J Clin Invest, 2004, 113: 516-527.
  • 8Bauditz J, Schachschal G, Wedel S, Lochs H. Thalidomide for treatment of severe intestinal bleeding. Gut, 2004,53:609-612.
  • 9戈之铮,胡运彪,高云杰,萧树东.胶囊内镜的临床应用[J].中华消化杂志,2003,23(1):7-10. 被引量:98
  • 10戈之铮,胡运彪,萧树东.胶囊内镜与推进式小肠镜诊断不明原因消化道出血的评价[J].中华消化内镜杂志,2003,20(4):223-226. 被引量:87

共引文献10

同被引文献14

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部